News

Updates from NHS BSA, MHRA drug safety alerts, and other medical news.

MHRA Alert – SABA Overuse in Asthma: Safety Reminder and Prescribing Guideline Changes

MHRA Safety Reminder: Short-Acting Beta 2 Agonist Overuse Healthcare professionals and patients are reminded of the significant risks associated with overuse of short-acting beta 2 agonists (SABA) in asthma management. The MHRA has issued this alert to reinforce existing safety guidance and highlight recent changes to SABA prescribing recommendations. Key Safety Points Overuse of SABA—with […]